The prevalence and 14 year incidence of clinical gout and its precursors were investigated in the Polynesian population of Tokelauans living in the Pacific basin, non-migrant Tokelauans living in their isolated atoll homeland being compared with migrant Tokelauans living in urban New Zealand. The age standardised prevalence of gout in Tokelauan men in New Zealand was higher than that in non-migrant Tokelauan men, being 21-0 and 19*5/1000 subjects at the beginning of the study and 51.0 and 14.6/1000 at the end of study, respectively. Migrant men in New Zealand aged under 55 had higher mean serum uric acid concentrations than non-migrant men of the same age. The prevalence of gout was low in women in both environments. The age standardised relative risk of developing gout between 1968 and 1982 was 9.0 times higher in the migrant men than in the non-migrant men. Age, serum uric acid concentration, serum cholesterol concentration, and self reported alcohol consumption at entry to the study were the best set ofpredictors of gout in men.
lence surveys have been carried out, but only one prospective survey has been reported in Polynesians. 6 This was a study of New Zealand Maoris, which reported a baseline prevalence of gout of 8-8% and a high incidence of 10 3/100 subjects over 11 years.
Changes in uric acid concentrations and in the prevalence of gout in response to urbanization and apparent modernisation have not, however, been uniform in all Polynesians and have varied in different studies.4 -9 An earlier study comparing Hawaiians with New Zealand Maoris suggested that they had similar patterns of obesity and hypertension but that the Hawaiians had low serum uric acid concentrations and no gout.'0 More recent studies of Micronesians in Nauru have shown high rates of hyperuricaemia (64%) and gout (6 9%) in men.9 This is thought to be related to their extraordinary affluence and lifestyle based on their prosperous phosphate economy. Also in the Pacific a recent study from Japan suggested that urbanisation and change to a diet with a higher intake of animal protein and fat was causing an increase in hyperuricaemia and gout."
The Tokelau Island migrant study, established in 1967 as a multidisciplinary investigation of migration and health in Tokelauans, provided an opportunity to examine the specific effect of urbanisation on the prevalence and incidence of gout in a genetically homogeneous group.'2 The unique feature of the study was the documentation of the health of migrants from isolated Tokelau to urban New Zealand both before and after migration. 13 14 Tokelau consists of three small isolated atolls (Fakaofo, Nukunonu, and Atafu) 3200 km north of New Zealand. Since the mid1960s a large proportion of its population has migrated to New Zealand so that by 1982 nearly two thirds of all Tokelauans (2800 out of 4360) were living in New Zealand. Life in Tokelau follows a traditional pattern with a subsistence economy dependent on fishing and harvesting of copra, which is exported to Western Samoa. In recent years more salaried positions have been established with the development of the Tokelau Public Service and stores have become better equipped and able to offer a wider range of foods, including rice, flour, and sugar. The staple diet consists of coconuts, which give about 54% of energy, fish, and breadfruit supplemented by rice, flour, and sugar. '5 16 The diet of islanders who migrate to New Zealand undergoes a major change, with an increase in the proportion of meat, carbohydrates, and dairy products including milk and cream. The overall energy intake is higher in New Zealand. '6 In Tokelau in the mid1970s the total fat intake, which comes largely from coconut, accounted for 48% of energy and saturated fat yielded 43% of The relation between a subject's health state at entry to the study and the subsequent development of gout was investigated. Those developing gout were compared with the rest of the population for their mean body mass index, weight (kg), height (cm), upper arm circumference (cm), subscapular and triceps skinfold thicknesses (mm), systolic and fourth phase diastolic blood pressures (mm Hg), and serum cholesterol, triglyceride, and uric acid concentrations (mmol/l) at entry. A composite measure of upper arm muscle circumference was also included; this had been associated with the incidence of gout in a previous study.6 The analysis ofincidence was confined to men as there were too few cases among women for a useful comparison. The difference between the age distributions of people developing gout and those not was controlled for by analysis of covariance.
Univariate and forward stepwise multivariate logistic regression analyses were also carried out. 23 Included as candidate predictors of disease state were the independent variables listed above together with a dummy variable indicating whether a person had spent any time in New Zealand during the study (O=no exposure, 1=exposure). Also included was a second dummy variable indicating the self reported current alcohol consumption at entry (O=no, 1 =yes). Predictors were included in the "best" model if they were significant at the 5% level after the effects of other variables already included had been controlled for. Multiple logistic regression permits the estimation of relative risks adjusted for the other independent variables. Multicollinearity was not a problem in selecting the best predictors.
Significance was assessed at the nominal 5% level for all comparisons made. Calculations were facilitated by the Statistical Analysis System.24
Results

PREVALENCE
The place, sex, and age specific prevalences of gout in rounds I and III suggested that gout was more common in migrants than non-migrants and men than women, occurred in younger migrants, and became more common as the migrants stayed longer in New Zealand (table I) . This was confirmed by statistical analysis of the age standardised prevalences (table II) .
Over the three examination rounds the age standardised prevalence of gout was higher in the migrant than the non-migrant men but significantly so only at round III, when the estimated relative risk of gout of 3-7 was significantly higher among migrant men (X2 (1)=8 67; p<001). A test for trend in prevalence over the three rounds showed a significant increasing linear trend ofprevalence among migrant men (X2 (1)=8851; p<OOl) but not among non-migrant men (X2 (1)=0 39; p=0 53). The age standardised prevalence of gout in the women was not analysed because of the few cases.
In men and women migrants and non-migrants at round II mean serum uric acid concentrations increased with age. In controlling for age in cross sectional comparisons of the mean concentrations it was necessary to split the men into two age groups to satisfy the statistical assumption that the regressions with age for migrants and non-migrants were parallel. Thus in round III migrant men younger than 55 had an adjusted mean serum uric acid concentration that was 0-017 mmol/l above that of the non-migrants of the same age (p=0-002). Older men migrants (55 and over) had an average concentration 0-028 mmol/l lower than that oftheir non-migrant compatriots (p=004). A similar pattern was seen for round II, although this was not significant (p=0-58). Non-migrant women in round II had a significantly higher mean concentration than migrants by 0-01 mmol/l (p=0 04), but by round III the difference in women was not significant (p=027). Table III shows these results.
459 differences were found. The amount of variability about the means was generally larger in the people developing gout than in the remainder of the population. considered, apart from age and height, were positively associated with the incidence of gout so that an increase in each risk factor contributed directly or indirectly to an increase in risk. For example, in the univariate logistic regression model when the serum uric acid concentration was used, the relative risk of gout for an increase from 0-36 to 0-48 mmol/l was 5-12 (95% confidence interval 3-06 to 8 56). This particular logistic regression analysis contained a bias due to the laboratory bias in serum uric acid estimations for those 231 people whose round I data came from the 1971 survey. Analyses excluding these people, however, as well as analyses using only round II and round III data, suggested that the extent of the bias in the estimated relation between the incidence of gout and serum uric acid concentration was negligible.
Forward stepwise multivariate logistic regression analysis showed that the best set of entry predictors of gout were age, serum uric acid concentration, alcohol use, and serum cholesterol concentration. This model accounted for 204% of the total variance. The relative risk of developing clinical gout for an increase in serum uric acid concentration from 0-36 to 0A48 mmol/l was 5-31 (confidence interval 3 01 to 9 08); for cholesterol the relative risk for an increase from 3 99 to 6-41 mmol/l was 3 25 (confidence interval 1-36 to 7 78); and for self reported current alcohol users the relative risk was (confidence interval 1-40 to 8 04). A model including the body mass index instead of cholesterol concentration accounted for almost as much of the variance (20 3%) and might be preferred by clinicians as body mass is easier to measure and is non-invasive. In this model the relative risk of having clinical gout was 1-70 (confidence interval 1-13 to 2 58) for an increase of 0 5 in the body mass index. Cox's proportional hazards regression was also used because it was a potentially more powerful tool for analysing these data. 23 Because of the imprecision in ascertaining the onset of gout, however, the results of this analysis were closely comparable with those from the logistic analysis and yielded similar values for the various relative risks.
Discussion
Over the 14 years of this study the prevalence of gout in Tokelau showed a minor, but not significant, decrease from 19-5/1000 subjects in round I to 14-6/1000 in round III. In the first survey round in New Zealand the prevalence of gout was only marginally higher in migrant men (21 0/1000) compared with non-migrant men (19 5/1000 ). An increase became apparent at the second round, when the prevalence in the migrant men reached 35-0/1000; it increased to 51 0/1000 in the third round. As both non-migrants and migrants are of the same genetic admixture these changes highlight the important response to environmental changes that occur in migrants at risk for gout.
Among the Tokelauan men in New Zealand the high overall incidence of gout (90 7/10 000 person years at risk) places them in the same high risk class as New Zealand Maoris.6 In Tokelau the incidence was much lower at 11 2/10 000 person years at risk. Age specific incidences showed that gout was occurring earlier in migrant men than non-migrant men. In the migrant men the largest number of new cases occurred among those aged 35-44, whereas in the non-migrant men it occurred among those aged 45-54. This pattern was evident in the prevalence data. Gout was fairly uncommon in women in both environments.
These results are most unlikely to be the result of bias, as although there were several possible sources of bias, its magnitude was thought to be small. Measurable follow up bias was unlikely with the high coverage rates in this study; also unlikely was misclassification of the presence or absence of gout. Many Tokelauans, both migrants and non-migrants, were known to have travelled back and forth between Tokelau and New Zealand. This is unlikely to have caused more than a small bias in attributing overall person years at risk to the two environments, particularly as people were excluded from the incidence study at the first examination after their return to Tokelau.
Expanded uric acid pools associated with the deposition of uric acid in and around joints is linked to the clinical occurrence of gout. 25 The serum uric acid concentrations in both round II and round III were significantly higher in the migrants under 55 than in the non-migrants, which could be in response to a strong environmental effect. Concentrations in the older migrants were lower than those in the non-migrants. The difference in the incidence of gout between Tokelau and New Zealand may be related to several factors influencing purine metabolism associated with a build up of the total uric acid pool. The higher meat consumption in the migrants, the purine content of beer, the influence of alcohol on renal uric acid clearance, and the effect of a gain in body weight and increased muscle mass could all be contributing factors to the putative expanded uric acid pools in the migrants.
In the multivariate analysis age, serum uric acid and cholesterol concentrations, and self reported consumption of alcohol, all measured at entry, were significantly associated with the incidence of gout, and they may be regarded as the best predictive risk factors for gout. The mean body mass at entry was greater among those people who later developed gout than among those who remained gout free and was also a predictor of the incidence of gout in an alternative multivariate model. It should be noted that the subjects were already somewhat overweight before migration and that, overall, weights increased to a greater degree in the migrants than the non-migrants. Upper arm muscle circumference was shown to be a predictor of gout in the New Zealand Maori study6 as well as in our population.
Earlier work showed a relation between alcohol intake and serum uric acid concentration in Polynesians. 4 The pattern of alcohol use is changing in Tokelauans both in New Zealand and in Tokelau; this represents changing attitudes to its use in both places. 26 The age standardised prevalence of self reported current alcohol use in rounds I and III was 63% and 73% for migrant men in New Zealand and 36% and 62% for non-migrant men in Tokelau, respectively. Alcohol usage is greater in New Zealand than Tokelau.
Information concerning the mechanisms for the development of gout is not directly available from this study of Tokelauans. Recent work on a sample of 115 Maori men in New Zealand showed a lower urate clearance in gouty and hyperuricaemic subjects.5 This suggested that the susceptibility to hyperuricaemia had a renal mechanism in Maoris. Further studies are needed to elucidate these mechanisms in Tokelauan and other Pacific Islanders.
This study showed that the Tokelauan population has high serum uric acid concentrations, which are higher in younger migrants than non-migrants. The risk of gout was increased in the migrants, with a notably higher prevalence and incidence associated with urbanisation and a move to a more Western diet and lifestyle. An important genetic predisposition to gout may be present that is enhanced by the effects of migration. Prevention of weight gain through moderate dietary changes, prudent use of alcohol, and increased physical activity will help prevent gout in migrant Tokelauans. Patients with the disease should be supervised to achieve compliance with treatment regimens. These measures should also help to prevent associated disorders such as hypertension and diabetes.
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Subjects and methods
Study population-The adults studied consisted of 3953 out of a total of roughly 7000 adults in the Busselton electorate who were asked to participate in the 1981 Busselton health survey. Their ages ranged from 18 to 88 (mean 49-6). Five consecutive adults out ofeach 15 attending for the survey (that is, 889 of 2670) were skin tested. All primary schools in the Busselton electoral area and one of the two high schools were surveyed in 1983. Over 95% of children attending school on the day of the visit completed a questionnaire. The children's ages ranged from 6 to 19 (mean . A total of 1307 children were skin tested. The first 400 were selected by testing every second child surveyed while the 907 others were selected by testing every child surveyed.
Measurement ofhistamine sensitivit-Each subject was prick tested by the method of Pepys5 with four dilutions of histamine phosphate dissolved in phosphate buffered saline and a control solution of the saline alone. Two diameters of any weals that resulted were recorded 15 minutes after application of the solution and the mean diameter recorded. The lowest concentration of histamine that produced a weal diameter of at least 2 mm was designated the histamine threshold concentration for that subject. The concentrations of histamine used were 1-0, 0-1, 0-01, and 0-001 mg/ml. Subjects not responding to 1-0 mg/ml were said to have a histamine threshold concentration of 10 mg/ml. Correction for responses to the control saline was not attempted; 83 (9 2%) adults and 14 (1-1%) children responded to the control saline.
Allergen prick testing-All subjects were prick tested by the method of Pepys5 with 14 allergens-namely, six local grass pollens, two weeds, one tree pollen, cattle, cat, and dog danders, and extracts of aspergillus and Dermatophagoides farinae in 50% glycerinated saline (Holister-Stier Laboratories, Spokane, Washington, United States).3 Allergen groups were defined on the basis of strong cross reactivity. Thus a positive response to any one offive grass extracts (in adults) or six grass extracts (in children) was considered a positive reaction to the grass group. Two weed and two house dust mite extracts were treated similarly. This resulted in eight different allergen groups for adults and seven for children. Weals with an average diameter of at least 2 mm were counted as a positive response.
Measurement ofIgE concentration-Total serum IgE concentrations were measured in a subset of 400 adults by PRIST (Pharmacia Diagnostics, Uppsala, Sweden). Subjects were selected for one of three reasons. (1) They had previously given a positive result on bee venom radioallergosorbent testing (n=110). (2) They had been previously HLA typed (selection for typing was random) (n=220). (3) They were part of a family study on IgE (families were not selected for allergic symptoms or high IgE concentration) (n=70).
Definition ofhayfever-The diagnosis ofallergic rhinitis and hay fever was made by questionnaire. Subjects were asked to answer the following questions with a yes or no. Have you ever had longlasting or frequent: (a) blockage ofthe nose, nasal stuffiness? (b) watery discharge from the nose? and (c) sneezing or itching of the nose, roof of mouth, or throat? (d) are the symptoms still present? They were also asked to circle the month(s) of the year when the symptoms in questions (a), (b), and (c) were present and when
